Product Brief
Semaglutide is a long-acting GLP-1 receptor agonist widely used in appetite regulation and metabolic support programs. Its extended half-life makes it a staple choice for sustained protocol designs.
Engineered for extended receptor engagement, Semaglutide provides sustained GLP-1 pathway activation that supports appetite control and metabolic balance over longer protocol windows without frequent re-dosing complexity.
Every Radiptide batch is manufactured under strict quality control and tested for identity and purity. Certificate of Analysis (COA) available on request.